Design, Synthesis, and Pharmacological Evaluation of Novel 2-(4-substituted piperazin-1-yl)1, 8 Naphthyridine 3-Carboxylic Acids as 5-HT3 Receptor Antagonists for the Management of Depression

被引:9
作者
Dhar, Arghya K. [1 ]
Mahesh, Radhakrishnan [1 ]
Jindal, Ankur [1 ]
Devadoss, Thangaraj [1 ]
Bhatt, Shvetank [1 ]
机构
[1] Birla Inst Technol & Sci, Dept Pharm, Pilani 333031, Rajasthan, India
关键词
1,8-naphthyridine; 5-HT3 receptor antagonist; anti-depressant; forced swim test; tail suspension test; ANTIDEPRESSANTS; PIPERAZIN-1-YL)-1,8-NAPHTHYRIDINE-3-CARBONITRILE; BURDEN; RATS;
D O I
10.1111/cbdd.12370
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
1, 8-naphthyridine-3-carboxylic acid analogs were synthesized and found to possess potential 5-HT3 receptor antagonism as well as antidepressant-like activity. Initially, 5-HT3 receptor antagonism of all the compounds was determined in the form of pA(2) value against agonist 2-methyl 5-HT in longitudinal muscle-myenteric plexus preparation from guinea-pig ileum. Among all the compounds tested, compound 7a demonstrated most promising pA(2) value of 7.6. Subsequently, all the compounds were evaluated for antidepressant activity using forced swim test and tail suspension test in mice. Compounds 7a, 7d, 7f, 7h, and 7i exhibited significant (p<0.05) antidepressant-like activity as compound to vehicle-treated group. Importantly, none of the tested compound affected locomotor activity of mice at tested dose levels.
引用
收藏
页码:721 / 731
页数:11
相关论文
共 44 条
[1]   A review of central 5-HT receptors and their function [J].
Barnes, NM ;
Sharp, T .
NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152
[2]  
BOISSIER JR, 1965, ARCH INT PHARMACOD T, V158, P212
[3]   Acute treatment with 5-HT3 receptor antagonist, tropisetron, reduces immobility in intact female rats exposed to the forced swim test [J].
Bravo, Gabriela ;
Maswood, Sharmin .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2006, 85 (02) :362-368
[4]  
Cappelli Andrea, 2002, Current Topics in Medicinal Chemistry, V2, P599, DOI 10.2174/1568026023393813
[5]   ANXIOLYTIC POTENTIAL OF 5-HT3 RECEPTOR ANTAGONISTS [J].
COSTALL, B ;
NAYLOR, RJ .
PHARMACOLOGY & TOXICOLOGY, 1992, 70 (03) :157-162
[6]   Effect of acute and chronic treatment with QCF-3 (4-benzylpiperazin-1-yl) (quinoxalin-2-yl) methanone, a novel 5-HT3 receptor antagonist, in animal models of depression [J].
Devadoss, Thangaraj ;
Pandey, Dilip K. ;
Mahesh, Radhakrishnan ;
Yadav, Shushil K. .
PHARMACOLOGICAL REPORTS, 2010, 62 (02) :245-257
[7]   EFFECTS OF ANTIDEPRESSANTS ON THE INWARD CURRENT MEDIATED BY 5-HT3 RECEPTORS IN RAT NODOSE GANGLION NEURONS [J].
FAN, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (03) :741-744
[8]   Adolescent depression: Description, causes, and interventions [J].
Hankin, BL .
EPILEPSY & BEHAVIOR, 2006, 8 (01) :102-114
[9]   CONFORMATION-ACTIVITY RELATIONSHIP STUDY OF 5-HT3 RECEPTOR ANTAGONISTS AND A DEFINITION OF A MODEL FOR THIS RECEPTOR-SITE [J].
HIBERT, MF ;
HOFFMANN, R ;
MILLER, RC ;
CARR, AA .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (06) :1594-1600
[10]   A Review of Granisetron, 5-Hydroxytryptamine3 Receptor Antagonists, and Other Antiemetics [J].
Hsu, Eric S. .
AMERICAN JOURNAL OF THERAPEUTICS, 2010, 17 (05) :476-486